scholarly journals Supraventricular Tachycardia and Tricuspid Regurgitation in the Setting of Misplaced Implantable Port Catheter Tip

Cureus ◽  
2017 ◽  
Author(s):  
Ahmad Awan ◽  
Bisma Ahsan ◽  
Hasan Iftikhar ◽  
Akbar Khan ◽  
Fasil Tiruneh ◽  
...  
Keyword(s):  
Supraventricular Tachycardia ◽  
Tricuspid Regurgitation ◽  
Port Catheter ◽  
Catheter Tip ◽  
Implantable Port

Repeated Bland-TAE Using Small Microspheres Injected via an Implantable Port–Catheter System for Liver Metastases: An Initial Experience

2013 ◽  
Vol 37 (2) ◽  
pp. 493-497 ◽  
Author(s):  
Toshihiro Tanaka ◽  
Hideyuki Nishiofuku ◽  
Shinsaku Maeda ◽  
Testuya Masada ◽  
Hiroshi Anai ◽  
...  
Keyword(s):  
Liver Metastases ◽  
Initial Experience ◽  
Port Catheter ◽  
Catheter System ◽  
Implantable Port

scholarly journals Cardiac Magnetic Resonance for Evaluating Catheter Related FDG Avidity

2016 ◽  
Vol 2016 ◽  
pp. 1-4
Author(s):  
Daniel Jeong ◽  
Kenneth L. Gage ◽  
Claudia G. Berman ◽  
Jaime L. Montilla-Soler
Keyword(s):  
Cardiac Magnetic Resonance ◽  
Magnetic Resonance ◽  
Superior Vena ◽  
Vena Cava ◽  
Port Catheter ◽  
Positron Emission ◽  
Pet Ct ◽  
Catheter Tip ◽  
History Of ◽  
Fdg Avidity

A 53-year-old female with a history of metastatic left arm melanoma presented for F(18) fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) which showed a moderately FDG avid focus at her port catheter tip near the cavoatrial junction. Although catheter tip related FDG avidity has previously been suggested to be bland thrombus or infection, melanoma can metastasize to unusual locations including the superior vena cava. In addition, the patient had an elevated risk of anticoagulation due to a history of hemorrhagic brain metastases. Therefore, confirmatory cardiac magnetic resonance (CMR) was obtained and findings were consistent with bland catheter-related thrombus.

Administration of 24-hour intravenous infusions of trabectedin every 3 weeks in ambulatory patients with mesenchymal tumors via disposable elastomeric pumps

2009 ◽  
Vol 27 (15_suppl) ◽  
pp. e13530-e13530
Author(s):  
P. Schoeffski ◽  
L. Cerbone ◽  
P. Wolter ◽  
M. Stas ◽  
H. Dumez ◽  
...  
Keyword(s):  
Local Relapse ◽  
Routine Practice ◽  
Port Catheter ◽  
Mesenchymal Tumors ◽  
Ambulatory Treatment ◽  
Primary Surgery ◽  
Best Response ◽  
Catheter Tip ◽  
Cost Efficient ◽  
Grade 3

e13530 Background: Patients (pts) with sarcoma whose disease progresses after standard chemotherapy have poor outcome. In this setting, DNA- transcription-interacting cytotoxic agent trabectedin (TRA) is efficacious and marketed in Europe. It is administered as 24-h i.v. infusion q3w with steroid co-medication. To overcome the inconvenience of hospitalization for drug delivery TRA is now given in Leuven via disposable elastomeric pumps, which facilitate ambulatory treatment and are compatible with the drug. Material and Methods: Heavily pre-treated pts with sarcoma were offered chemotherapy with TRA 1.5 mg/m2 as 24-h i.v. infusion via port catheter, either during hospitalization using electronic pumps or as outpatients using the Baxter LV10 disposable pump (drug dissolved in 267 ml NaCl 0.9%). Co-medication consisted of antiemetics and dexamethasone 2x4 mg days -1,1,2,3. Results: Between 09/07–12/08 28 pts were treated, and 21 (75%) elected outpatient therapy (9 F, 12 M, med. age 49 yrs, range 19–68). Common diagnoses included leiomyo- (5), lipo- (4), synovial (2) and myxofibrosarcomas. Pts had previous primary surgery (17), adjuvant RT (4) and surgery for relapse/metastasis (7). They had local relapse (2), distant metastasis (12) or both (7) when starting TRA, 19 had received previous chemotherapy with a med. number of 2 prior lines (range, 0–5). We administered 130 cycles of TRA in 21 pts, with a med. number of 3 cycles/patient (range, 1–24). Dose reductions were done in 60 cycles, mainly due to laborabory events. Best response (RECIST) was 3 confirmed PR, 1 PR pending confirmation, 6 SD, 11 PD. Grade 3/4 (CTC) AEs were limited to one case each of hemorrhage and lung embolism, other AEs were in line with published TRA experience. One port catheter contamination required replacement, one catheter tip thrombosis occurred and one extravasation due to needle dislocation was observed. Conclusions: Outpatient administration of TRA as 24-h infusion via port catheter using Baxter LV10 pumps is preferred by 3/4 pts, is feasible, safe, effective, cost-efficient and should be considered routine practice in this clinical setting. [Table: see text]

Sign in / Sign up

Export Citation Format

Share Document